ArticleCirculation reports2026
Establishment of Ascertainment Methods for Cardiovascular Disease Onset in the Tohoku Medical Megabank Organization.
Article in Circulation reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In order to collect information on the onset of cardiovascular disease (CVD) events for participants, the Tohoku Medical Megabank Organization (ToMMo) constructed a system to identify CVD events using a self-administered questionnaire regarding CVD onset. The association between traditional cardiovascular risk factors and CVD onset was also examined. Methods and Results: This study included participants from the ToMMo's Community-based Cohort Study and the Birth and Three-Generation Cohort Study. To identify CVD onset, the participants were first asked about stroke, myocardial infarction, and angina pectoris using self-administered questionnaires. Next, for those reporting onset, the ToMMo mailed structured CVD registration forms to their medical institutions. These institutions used medical records to complete and return the forms. CVD onset was then determined at event adjudication meetings involving multiple physicians and epidemiologists, based on the information from these registration forms. A nested case-control study with 602 CVD cases and 1,204 matched controls using data from a Community-based Cohort Study of the ToMMo was conducted. Using conditional logistic regression models, we found significant association between traditional CVD risk factors, such as hypertension and dyslipidemia, and CVD onset. Conclusions: The ToMMo establishes a system for identifying CVD onset in cohort study participants. In the future, combining participants' lifestyles and genomic information with CVD onset may help build evidence for personalized prevention and medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.